Anirudh Jayanti, PhD

With deep expertise in economic and statistical analysis, Anirudh Jayanti specializes in life sciences and healthcare matters, particularly as related to antitrust issues, providing clients with rigorous insights and tailored solutions that help them navigate high-stakes disputes. His casework spans areas such as monopolization, mergers, false marketing claims, patent disputes, and reimbursement disagreements, where he has analyzed key issues like market power, market definition, competitive effects, causation, and damages.

Anirudh has experience supporting testifying experts and guiding clients in litigation and government investigations. Whether leading teams to develop clear and defensible analyses or delivering consulting support at critical junctures, Anirudh has a proven ability to remain calm under pressure and craft creative solutions to challenging problems. He takes pride in communicating technical findings in an accessible way and partnering with clients to achieve their strategic goals.

Beyond his casework, Anirudh is deeply invested in fostering professional growth and community within the firm. He serves as a sponsor in the Consultant Development Program, where he mentors team members and provides career guidance to help develop the next generation of consultants.

PhD, Economics, University of Michigan

MA, Economics, University of Michigan

AB, Economics and Mathematics, Dartmouth College

• Served as a consulting expert and led the team supporting the testifying expert in Regeneron Pharmaceuticals, Inc. v. Amgen Inc., a matter regarding alleged foreclosure from the PCSK9 inhibitor market through anticompetitive bundling of pharmacy benefits manager rebates. 
• Led the team supporting the expert on damages on behalf of a pharmaceutical manufacturer defendant concerning allegations of inappropriate marketing leading to lost profits for plaintiff hospitals.
• Co-led the team supporting the expert on behalf of a health insurer in its acquisition of a long-term care pharmacy. Submitted advocacy to the FTC regarding horizontal overlap and vertical competitive effects and assisted with second request compliance. The transaction was cleared without conditions.
• Supported testifying experts on behalf of a health insurer regarding alleged violations of the False Claims Act in connection with Medicare Part D formulary design.
• Supported the testifying expert on behalf of Actelion in Government Employees Health Association (GEHA) v. Actelion Pharmaceuticals LTD. regarding market definition and market power in connection with antitrust allegations of delayed generic entry.
• Supported the testifying expert on causation on behalf of a manufacturer defendant concerning allegations of inappropriate marketing of prescription opioids.
• In Sandoz Inc. and Raregen, LLC v. United Therapeutics Corporation and Smiths Medical ASD, Inc., provided support for the expert report of Dr. Eric Gaier regarding issues of market definition, market power, and competitive effects on behalf of United Therapeutics and Smiths Medical in connection with plaintiffs’ allegations of exclusionary contracts in violation of antitrust laws.
• In Veeva Systems Inc. v. IQVIA Inc., supported the testifying expert on behalf of Veeva on issues of market definition, market power, and competitive effects regarding monopolization of data and data management software for pharmaceutical companies.
• Supported the expert in two related intellectual property matters on behalf of a pharmaceutical manufacturer alleging infringement of patents on its brand-name drug against a generic manufacturer.
• In In re Determination of Rates and Terms for Making and Distributing Phonorecords, supported the expert in preparing testimony on behalf of Spotify USA Inc. regarding royalty payments under Section 115 of the Copyright Act.